Genomics: Clinical Implementation

This channel includes news headlines and educational resources regarding the clinical implementation of genomics assays, including development, validation, quality control, standardization, and the practical and commercial considerations for labs adopting these tests.

Illumina, Genomics England Ink Deal to Sequence up to 300K People

The deal provides whole-genome sequencing for patients with rare diseases or cancer and could make sequencing part of the standard of care for NHS England.

Genomic Testing Cooperative, C2i Collaborate on Liquid Biopsy Tests for Solid Tumors

GTC will sequence samples and help with technical and clinical validation, while C2i will perform AI-based analysis of the data, recruit samples, and perform other clinical trial activities.

Guardant Health to Develop Liquid Biopsy CDx for Amgen KRAS G12C Inhibitor

The company plans to submit a companion diagnostic version of its sequencing-based liquid biopsy test Guardant360 to various regulatory bodies.

Adaptive Biotechnologies, Genentech Partner on MRD Testing in Venetoclax Clinical Trial

Genentech will use Adaptive's ClonoSeq assay for MRD testing in a CLL study. Adaptive will receive upfront and sample testing payments of undisclosed amounts.

With More Than a Million Records, ClinVar Value Grows as Variant Classification Resource

Premium

In seven years, the public variant classification database has steadily become a resource that labs are submitting to and that genetics experts are consulting.

Jan 09, 2020

Natera Launches Study for Colorectal Cancer Cell-Free DNA Blood Test

Jan 06, 2020

US Senators Introduce Law to Enable WGS Testing on Children With Rare Diseases

Jan 02, 2020

Personalized Medicine in 2019: Options Increasing But Are They Reaching Patients?

Premium

Dec 20, 2019

Prostate Cancer Modeling Study Supports Precision Screening Approach

Dec 13, 2019

New Data Emerges for Liquid Biopsy in Breast Cancer Residual Disease Detection

Premium

Dec 13, 2019

UK Study Details Liquid Biopsy's Ability to Guide Metastatic Breast Cancer Treatment

Dec 12, 2019

ACMG Suggests Docs Evaluate All Breast Cancer Patients for Genetic Risk Test Suitability

Dec 11, 2019

Study Shows Feasibility of Circulating Trophoblast-Based Noninvasive Prenatal Testing

Premium

Dec 11, 2019

At ASH, Researchers Discuss Rapid AML Nanopore Sequencing Assay for Analyzing Actionable Alterations

Dec 10, 2019

KU-Led Team Begins Clinical Validation of Microfluidic Device for Leukemia MRD Detection

Premium

Dec 04, 2019

NCCN Updates Genetic Testing Guidelines for Assessing Breast, Ovarian, Pancreatic Cancer Risk

Nov 25, 2019

Primary Care Professionals May Be Able to Step in to Interpret Genetic Testing Results

Nov 22, 2019

Racial Group Comparison Suggests More Research Needed on Prostate Cancer Recurrence Tests

Premium

Nov 15, 2019

Employee Benefits Programs Share Early Experiences Implementing Genetic Testing

Premium

Nov 13, 2019

ACMG, ClinGen Publish Recommendations for Interpretation, Reporting of CNVs

Nov 12, 2019

AMP Attendees Reflect on Uptake of Tumor Mutational Burden Amid Validation, Utility Questions

Premium

Nov 08, 2019

Some Call for Expanded Payor Coverage of NIPS but Reluctance Remains

Premium

Nov 06, 2019

U of Vermont Health Network Launches DNA Risk Screening Pilot Program

Oct 29, 2019

CMS Proposes New National Coverage Policy for NGS Germline Testing

Oct 18, 2019

Menu

Genomics: Clinical Implementation

Illumina, Genomics England Ink Deal to Sequence up to 300K People

Genomic Testing Cooperative, C2i Collaborate on Liquid Biopsy Tests for Solid Tumors

Guardant Health to Develop Liquid Biopsy CDx for Amgen KRAS G12C Inhibitor

Adaptive Biotechnologies, Genentech Partner on MRD Testing in Venetoclax Clinical Trial

With More Than a Million Records, ClinVar Value Grows as Variant Classification Resource

Natera Launches Study for Colorectal Cancer Cell-Free DNA Blood Test

US Senators Introduce Law to Enable WGS Testing on Children With Rare Diseases

Personalized Medicine in 2019: Options Increasing But Are They Reaching Patients?

Prostate Cancer Modeling Study Supports Precision Screening Approach

New Data Emerges for Liquid Biopsy in Breast Cancer Residual Disease Detection

UK Study Details Liquid Biopsy's Ability to Guide Metastatic Breast Cancer Treatment

ACMG Suggests Docs Evaluate All Breast Cancer Patients for Genetic Risk Test Suitability

Study Shows Feasibility of Circulating Trophoblast-Based Noninvasive Prenatal Testing

At ASH, Researchers Discuss Rapid AML Nanopore Sequencing Assay for Analyzing Actionable Alterations

KU-Led Team Begins Clinical Validation of Microfluidic Device for Leukemia MRD Detection

NCCN Updates Genetic Testing Guidelines for Assessing Breast, Ovarian, Pancreatic Cancer Risk

Primary Care Professionals May Be Able to Step in to Interpret Genetic Testing Results

Racial Group Comparison Suggests More Research Needed on Prostate Cancer Recurrence Tests

Employee Benefits Programs Share Early Experiences Implementing Genetic Testing

ACMG, ClinGen Publish Recommendations for Interpretation, Reporting of CNVs

AMP Attendees Reflect on Uptake of Tumor Mutational Burden Amid Validation, Utility Questions

Some Call for Expanded Payor Coverage of NIPS but Reluctance Remains

U of Vermont Health Network Launches DNA Risk Screening Pilot Program

CMS Proposes New National Coverage Policy for NGS Germline Testing

Colon Cancer Recurrence Clues Identified in Post-Treatment ctDNA Detection

Sponsorships